Addex Therapeutics Ltd has leveraged more than a decade of research into addiction with a partnership that will see it co-develop a portfolio product with Indivior Plc, a London-listed and US headquartered specialty pharmaceutical company. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
